Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Anticancer Research|January 1, 1997
Cancer of the uterine cervix: clinical value of squamous cell carcinoma antigen (SCC) measurementsL Lozza, M Merola, R Fontanelli, et al.International Journal of Cancer|September 15, 1988
Activation of mononuclear cells to be used for hybrid monoclonal antibody-induced lysis of human ovarian carcinoma cellsS M Pupa, S Canevari, R Fontanelli, et al.Gynecologic Oncology|September 1, 1996
Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: prognostic significance of node metastasesF di Re, G Baiocchi, R Fontanelli, et al.La Radiologia Medica|January 1, 1983
[Comparison of radiotherapy and surgery in the management of cervical cancer in stages Ib and II]F Volterrani, L Feltre, M Di Giuseppe, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 27, 2005
Prognostic factors in microinvasive cervical squamous cell cancer: long-term resultsF Raspagliesi, A Ditto, P Quattrone, et al.International Journal of Cancer|October 23, 1997
Generation and phenotypic characterization of new human ovarian cancer cell lines with the identification of antigens potentially recognizable by HLA-restricted cytotoxic T cellsV Ramakrishna, D R Negri, V Brusic, et al.American Journal of Clinical Oncology|June 1, 1990
Cisplatin and cyclophosphamide in advanced ovarian carcinoma: activity and toxicity of an ambulatory regimenM Zambetti, L Gianni, F Di Re, et al.The International Journal of Biological Markers|September 1, 1987
A double determinant radioimmunoassay Mov2-MOv8 for monitoring ovarian carcinomas: definition of the methodologyA Diotti, O Santoro, L Mantovani, et al.The International Journal of Biological Markers|October 1, 1989
Detection of Lewis(a) antigen in sera of ovarian carcinoma patients by MOv2-MOv8 double-determinant radioimmunoassayL Mantovani, V Azzini, S Canevari, et al.Gynecologic Oncology|November 1, 1992
Nondysgerminomatous tumors of the ovary treated with cisplatin, vinblastine, and bleomycin: long-term resultsG De Palo, M Zambetti, S Pilotti, et al.Pageof 4